当前位置: X-MOL 学术Mov. Disord. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Nicotinamide Riboside Improves Ataxia Scores and Immunoglobulin Levels in Ataxia Telangiectasia
Movement Disorders ( IF 7.4 ) Pub Date : 2021-09-13 , DOI: 10.1002/mds.28788
Stefanie J G Veenhuis 1, 2 , Nienke J H van Os 2, 3 , Anjo J W M Janssen 4 , Marjo H J C van Gerven 4 , Karlien L M Coene 5 , Udo F H Engelke 5 , Ron A Wevers 5 , Gerjen H Tinnevelt 6 , Rob Ter Heine 7, 8 , Bart P C van de Warrenburg 2, 3, 9 , Corry M R Weemaes 1 , Nel Roeleveld 8, 10 , Michèl A A P Willemsen 1, 2, 9, 11
Affiliation  

Treatment of animal models with ataxia telangiectasia (A-T) with nicotinamide riboside (NR) improved their neurological outcome and survival.

中文翻译:


烟酰胺核苷可改善共济失调毛细血管扩张症的共济失调评分和免疫球蛋白水平



用烟酰胺核苷 (NR) 治疗共济失调性毛细血管扩张 (AT) 动物模型可改善其神经系统结果和生存率。
更新日期:2021-09-13
down
wechat
bug